LAST PRICE - AT THE CLOSE
DRUG is DOWN -20% since the begininning of the year
DRUG is DOWN -15% BELOW 20 day SMA
DRUG is UP 21% ABOVE 200 day SMA
PROFITABLE: YES
EPS: $0.00695434
EARNINGS MOMENTUM: YES
1.02% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 63.5% AWAY FROM ALL-TIME HIGHS OF $79.02 |
 |
DRUG IS DOWN -20% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 2188% OVER THE PAST 12 MONTHS |
 |
DRUG IS DOWN -20% OVER THE PAST 1 MONTH |
 |
2% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New premarket high. ... | 04/11 |
 | New premarket low. ... | 04/11 |
 | Up 7% for the day. | 04/11 |
 | Trading 4% above VWA... | 04/11 |
 | Trading 1% below VWA... | 04/11 |
 |
DRUG moved up 0 in the previous minute |
 |
DRUG is up 0 over the last hour |
 |
DRUG is up 10.1% over the last 5 days |
 |
DRUG is 5.7 above its 8 day SMA |
| $28.11 |   DAY |
$30.86 |
| $26.96 | PREVIOUS DAY |
$29.96 |
| $26.96 |  WEEK |
$33.65 |
| $26.96 | MONTH |
$38.33 |
| $0.93 | YEAR |
$79.02 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
